Ameriprise
ITCI

Ameriprise’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-38,956
Closed -$5.14M 4117
2025
Q1
$5.14M Sell
38,956
-483,607
-93% -$63.8M ﹤0.01% 2289
2024
Q4
$43.6M Sell
522,563
-7,633
-1% -$638K 0.01% 905
2024
Q3
$38.8M Buy
530,196
+186,375
+54% +$13.6M 0.01% 966
2024
Q2
$23.5M Sell
343,821
-68,375
-17% -$4.68M 0.01% 1178
2024
Q1
$28.5M Buy
412,196
+308,009
+296% +$21.3M 0.01% 1086
2023
Q4
$7.46M Buy
104,187
+31,667
+44% +$2.27M ﹤0.01% 2039
2023
Q3
$3.78M Sell
72,520
-5,200
-7% -$271K ﹤0.01% 2493
2023
Q2
$4.92M Sell
77,720
-3,009
-4% -$191K ﹤0.01% 2356
2023
Q1
$4.37M Buy
80,729
+31,245
+63% +$1.69M ﹤0.01% 2412
2022
Q4
$2.62M Buy
49,484
+42,117
+572% +$2.23M ﹤0.01% 2690
2022
Q3
$343K Sell
7,367
-1,352
-16% -$62.9K ﹤0.01% 3533
2022
Q2
$498K Buy
8,719
+1,235
+17% +$70.5K ﹤0.01% 3392
2022
Q1
$458K Buy
+7,484
New +$458K ﹤0.01% 3518
2020
Q1
Sell
-8,386
Closed -$288K 3753
2019
Q4
$288K Buy
+8,386
New +$288K ﹤0.01% 3486
2019
Q3
Sell
-11,500
Closed -$149K 3763
2019
Q2
$149K Buy
+11,500
New +$149K ﹤0.01% 3604
2016
Q3
Sell
-8,460
Closed -$328K 3823
2016
Q2
$328K Buy
8,460
+150
+2% +$5.82K ﹤0.01% 3334
2016
Q1
$231K Sell
8,310
-52,508
-86% -$1.46M ﹤0.01% 3465
2015
Q4
$3.27M Buy
60,818
+18,359
+43% +$987K ﹤0.01% 2323
2015
Q3
$1.7M Sell
42,459
-5,261
-11% -$211K ﹤0.01% 2696
2015
Q2
$1.53M Buy
+47,720
New +$1.53M ﹤0.01% 2881
2014
Q4
Sell
-5
Closed 4489
2014
Q3
$0 Buy
+5
New ﹤0.01% 5866